GLP1R and obesity due to melanocortin 4 receptor deficiency: The most common indication for GLP‐1 RAs other than diabetes mellitus is obesity, and further indications are under investigation, including: osteoarthritis; obstructive sleep apnoea; metabolic dysfunction‐associated steatotic liver disease; and metabolic dysfunction‐associated steatohepatitis [4].